NCT02605161
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- The Ottawa Hospital Ottawa, Ontario, Canada
Clinical trial condition
Synucleinopathies
Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.
3,503 public trials
645 recruiting studies
Synucleinopathies trial results
NCT03820037
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Covance Clinical Research Leeds, United Kingdom
NCT02968433
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Stanford Movement Disorders Clinic Stanford, California, United States
NCT04165278
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- Yingdong Zhang Nanjing, Jiangsu, China
Completed
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
NCT01474421
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Novartis Investigative Site Sacramento, California, United States
- Novartis Investigative Site Manhasset, New York, United States
- Novartis Investigative Site Cincinnati, Ohio, United States
- Novartis Investigative Site Cleveland, Ohio, United States
NCT01491932
- Conditions
- Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
- Locations
-
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Kansas City, Kansas, United States
- Novartis Investigative Site Milwaukee, Wisconsin, United States
- Novartis Investigative Site Innsbruck, Austria
NCT02702232
- Conditions
- Arthralgia, Basal Ganglia Diseases, Brain Diseases, +15 more
- Locations
-
- Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan
NCT01173731
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Novartis Investigative Site Sunnyvale, California, United States
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Indianapolis, Indiana, United States
- Novartis Investigative Site Heidelberg, Victoria, Australia
NCT01092065
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- The Parkinsons Institute Sunnyvale, California, United States
- Colorado Neurological Institute Englewood, Colorado, United States
- Indiana University School of Medicine Indianapolis, Indiana, United States
- University of Kansas Medical Center - Parkinson's Disease and Movement Disorders Center Kansas City, Kansas, United States
NCT01491529
- Conditions
- Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
- Locations
-
- Novartis Investigative Site Sunnyvale, California, United States
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Tampa, Florida, United States
- Novartis Investigative Site Kansas City, Kansas, United States